Entresto halves renal events in preserved EF heart failure patientsOctober 15, 2020DiabetesCardiologyEndocrinology
Female cardiac advantage essentially lost after MIOctober 13, 2020CardiologyMixed TopicsWomen's Health
T2D treatments create tension between glycemic and cardiovascular goalsOctober 12, 2020DiabetesPreventive CareCardiologyEndocrinology
Dapagliflozin’s CKD performance sends heart failure messagesOctober 5, 2020DiabetesEndocrinologyCardiologyNephrology
AHA scientific statement highlights cardiorenal benefit of new diabetes drugsOctober 1, 2020DiabetesCardiologyEndocrinology
New data challenge primary care’s inattention to aldosterone in hypertensionOctober 1, 2020CardiologyEndocrinology
Higher glycemic time in range may benefit T2D patientsSeptember 28, 2020DiabetesCardiologyEndocrinology
Exercise cuts diabetes death risk by a third in two studiesSeptember 28, 2020DiabetesCardiologyEndocrinology
DAPA-CKD resets eGFR floor for safe SGLT2 inhibitor useSeptember 25, 2020DiabetesMixed TopicsNephrologyEndocrinologyCardiology
